Skip to content

Characterization of Cancer Tissue Using 3D Biosynthetic Material

Characterization of Cancer Tissue Using 3D Biosynthetic Material

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02678078
Enrollment
100
Registered
2016-02-09
Start date
2016-02-29
Completion date
2018-01-31
Last updated
2016-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

cancer, diagnosis, biopsy, chemotherapy drugs, tumor

Brief summary

Characterization of Cancer Tissue Using 3D Biosynthetic Materials. Using liver biopsy from stage 4 cancer patients, the investigators will evaluate and characterize the metastatic cells.

Detailed description

The investigators' biomaterial lab has developed an in vitro diagnostic system in which a cancer tumor is placed inside a 3D hydrogel. This material has similar properties to the human tissue and can visualize cell migration and proliferation. In this system, the investigators have already characterised human metastatic cells obtained from nude mice tumors. The diagnostic assay is able to evaluate the reduction in cell growth associated with anti-cancer drug therapy. The next step is to test the in vitro diagnostic system using human tissue samples from human patients, and to validate the system as a simple and effective a priori diagnostic tool for characterizing patient tumours.

Interventions

PROCEDUREAnalyzing biopsy samples

Analyzing biopsy samples that is preformed as part of the patient treatment.

Sponsors

Rambam Health Care Campus
CollaboratorOTHER
Technion, Israel Institute of Technology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* liver tumor

Exclusion criteria

* refuse to volunteer

Design outcomes

Primary

MeasureTime frameDescription
cell growth1 weekbiopsy will be placed inside 3D gel, and growth will be measured over 1 week time.

Countries

Israel

Contacts

Primary Contacttarek Saadi, Dr.
t_saadi@rambam.health.gov.il97247772947
Backup Contactshlomit harpaz, Msc
shlomith@tx.technion.ac.il972544565257

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026